Bill Information for s1096-119

Long Title

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.

Short Title

Preserve Access to Affordable Generics and Biosimilars Act

Vote Information

Status: REPORTED as of 2025-04-03 00:00:00.

Sponsor: This bill was sponsored by Amy Klobuchar (D-MN).

Party line votes are determined based on this being a D-sponsored piece of legislation. See here for information on how party line votes are determined.

Vote count: There were 0 roll call votes on this bill in total.